Get started
ADDEX THERAP. SF 0,01ADDEX THERAP. SF 0,01ADDEX THERAP. SF 0,01

ADDEX THERAP. SF 0,01

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

APE chart


Full chart

APE upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.80 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
2.1725
Basic EPS (TTM)
0.0760 EUR
Net income (FY)
‪7.50 M‬ EUR
Revenue (FY)
‪436.13 K‬ EUR
Shares float
‪82.03 M‬
Beta (1Y)
0.37

Employees


Employees (FY)
2
Change (1Y)
−21 −91.30%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About ADDEX N


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Timothy Dyer
Website
addextherapeutics.com
Headquarters
Geneva
Founded
2002
ISIN
CH0029850754
FIGI
BBG000QVQ2N4
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

APE news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as APE.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ADDEX THERAP. SF 0,01 stocks are traded under the ticker APE.
We've gathered analysts' opinions on ADDEX THERAP. SF 0,01 future price: according to them, APE price has a max estimate of 0.17 EUR and a min estimate of 0.17 EUR. Watch APE chart and read a more detailed ADDEX THERAP. SF 0,01 stock forecast: see what analysts think of ADDEX THERAP. SF 0,01 and suggest that you do with its stocks.
Yes, you can track ADDEX THERAP. SF 0,01 financials in yearly and quarterly reports right on TradingView.
ADDEX THERAP. SF 0,01 is going to release the next earnings report on May 19, 2025. Keep track of upcoming events with our Earnings Calendar.
APE net income for the last quarter is ‪−1.28 M‬ EUR, while the quarter before that showed ‪−1.62 M‬ EUR of net income which accounts for 20.91% change. Track more ADDEX THERAP. SF 0,01 financial stats to get the full picture.
No, APE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 8, 2025, the company has 2 employees. See our rating of the largest employees — is ADDEX THERAP. SF 0,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ADDEX THERAP. SF 0,01 EBITDA is ‪−2.73 M‬ EUR, and current EBITDA margin is −608.50%. See more stats in ADDEX THERAP. SF 0,01 financial statements.
Like other stocks, APE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADDEX THERAP. SF 0,01 stock right from TradingView charts — choose your broker and connect to your account.